Categories: News

Mammalian Transient Protein Expression Market to Receive Tailwinds, with Growing Use in Biopharmaceutical Companies: Future Market Insights

Market players are focusing on expansion of their portfolios and strategic collaborations to attain licensing and distribution, and expanding geographical presence.

DUBAI, UAE / ACCESSWIRE / December 15, 2020 / The global mammalian transient protein expression market will be recording a steady CAGR over the forecast period, 2020 to 2030. The market has exhibited sturdy growth prospects with growing interest in terms of researchers and academics in the bio-medicine industry, influencing market expansion amid the projected period.

“A notable rise in R&D activities biotechnology, pharmaceutical, and biopharmaceutical market players to manufacture and develop advanced biologics comprising therapeutic proteins, vaccines, and monoclonal antibodies is fuelling demand. Furthermore, investments into drug expansion is significant to push long-term growth.” says an FMI analyst.

Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-12807

Key Highlights

  • North America, led by the US will remain dominant in the global market throughout the forecast period.
  • Reagents & consumables will be leading among other categories and accounting for over 33% of the overall market share.
  • Bio production applications is anticipated to record high growth rate over the forecast period.

Drivers

  • Progressions in genetic research is poised to generate prospects over the forecast period.
  • Recombinant protein therapeutic applications will be fueling demand for mammalian transient protein expression.
  • Rising demand from the biomedicine industry is anticipated to drive the market growth.

Restraints

  • Poor purification ensues in sub-optimum conditions, which might create a major operational challenge.
  • Poor media to resin ratios and adjustments in supernatant dialysis terms makes measures for instance strip-resistant nickel resins critical requiring additional effort and time, which would limit market prospects.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-12807

COVID-19 Impact on the Market

Social distancing regulations and strict lockdown owing to COVID-19 outbreak has ensued in delayed projects in research and biomedicine applications in the mammalian transient protein expression market. Key players have foreseen lower revenue and sales amid the crisis rising from disruptions of supply chain, and unavailability of adequate manpower. However, potential for use in vaccine development is projected to offer prospects for short-term expansion, moderately alleviating loss amid this period.

Competitive Landscape

Key players in the mammalian transient protein expression market are majorly engaged in launch of novel product offerings comprising antibody and gene coding production. Strategic agreements in terms of distribution and licensing, and geographical expansion are further gaining prominence.

Key market players operating in the global market are Thermo Fisher Scientific Inc., Lonza Group, Merck KgaA, Takara Bio Inc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Mirus Bio LLC, HiMedia Laboratories, Qiagen N.V., Sino Biological Inc. and Promega Corporation.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/12807

About the Study

The study offers readers a comprehensive assessment of the mammalian transient protein expression market. Global, regional and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights on the basis of Product Type (Instruments, Expression Vector, Reagents & Consumables, Cell Lines{Chinese Hamster Ovary Cells, Human Embryonic Kidney Cells and Others), Application ( Bio Production{Antibody Production and Therapeutic Protein Production}, Functional Cell Based Assays, Academic Research and Others), End User (Contract Research Organization, Biopharmaceutical Companies and Academic & Research Institutes), across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).

Table Of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Key Trends

1.3. Analysis & Recommendation

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

4. Key Success Factors

4.1. Protein Expression Technology Adoption Market Trends

4.2. Mammalian Transient Protein Expression Market – Forecast Factors – Relevance & Impact

5. Market Background

5.1. Macroeconomic Factors

5.2. Mammalian Transient Protein Expression Market : Opportunities

5.3. Mammalian Transient Protein Expression Market: Demand Side Drivers

5.4. Mammalian Transient Protein Expression Market: Supply side Drivers

5.5. Mammalian Transient Protein Expression Market: Restraints

Download Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-12807

Explore FMI’s Coverage of the Healthcare Industry

Radiation Toxicity Treatment Market: Obtain detailed analysis on the radiation toxicity treatment market through FMI’s report covering competitive analysis, key regions, and segmental analysis for 2019 – 2029.

Protein Crystallization and Crystallography Market: Get insights on the protein crystallization and crystallography market through FMI’s report covering detailed quantitative and qualitative analysis for projection period 2015 – 2025.

Plasma Protein System Market: FMI’s exhaustive study on the global plasma protein system market covers the latest trends, innovations, key players, and popular strategies for the period 2018 – 2028.

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/mammalian-transient-protein-expression-market
Press Release Source: https://www.futuremarketinsights.com/press-release/mammalian-transient-protein-expression-market

SOURCE: Future Market Insights

View source version on accesswire.com:
https://www.accesswire.com/620947/Mammalian-Transient-Protein-Expression-Market-to-Receive-Tailwinds-with-Growing-Use-in-Biopharmaceutical-Companies-Future-Market-Insights

Staff

Recent Posts

Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…

12 minutes ago

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…

12 minutes ago

Optinose Announces 1-for-15 Reverse Stock Split

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…

12 minutes ago

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…

13 minutes ago

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development…

13 minutes ago

SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation

TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or…

13 minutes ago